UniProt ID | ATF2_MOUSE | |
---|---|---|
UniProt AC | P16951 | |
Protein Name | Cyclic AMP-dependent transcription factor ATF-2 | |
Gene Name | Atf2 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 487 | |
Subcellular Localization | Nucleus. Cytoplasm. Mitochondrion outer membrane. Shuttles between the cytoplasm and the nucleus and heterodimerization with JUN is essential for the nuclear localization. Localization to the cytoplasm is observed under conditions of cellular stress | |
Protein Description | Transcriptional activator which regulates the transcription of various genes, including those involved in anti-apoptosis, cell growth, and DNA damage response. Dependent on its binding partner, binds to CRE (cAMP response element) consensus sequences (5'-TGACGTCA-3') or to AP-1 (activator protein 1) consensus sequences (5'-TGACTCA-3'). In the nucleus, contributes to global transcription and the DNA damage response, in addition to specific transcriptional activities that are related to cell development, proliferation and death. In the cytoplasm, interacts with and perturbs HK1- and VDAC1-containing complexes at the mitochondrial outer membrane, thereby impairing mitochondrial membrane potential, inducing mitochondrial leakage and promoting cell death. The phosphorylated form (mediated by ATM) plays a role in the DNA damage response and is involved in the ionizing radiation (IR)-induced S phase checkpoint control and in the recruitment of the MRN complex into the IR-induced foci (IRIF). Exhibits histone acetyltransferase (HAT) activity which specifically acetylates histones H2B and H4 in vitro. In concert with CUL3 and RBX1, promotes the degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM. Can elicit oncogenic or tumor suppressor activities depending on the tissue or cell type (By similarity).. | |
Protein Sequence | MSDDKPFLCTAPGCGQRFTNEDHLAVHKHKHEMTLKFGPARNDSVIVADQTPTPTRFLKNCEEVGLFNELASPFENEFKKASEDDIKKMPLDLSPLATPIIRSKIEEPSVVETTHQDSPLPHPESTTSDEKEVPLAQTAQPTSAIVRPASLQVPNVLLTSSDSSVIIQQAVPSPTSSTVITQAPSSNRPIVPVPGPFPLLLHLPNGQTMPVAIPASITSSNVHVPAAVPLVRPVTMVPSVPGIPGPSSPQPVQSEAKMRLKAALTQQHPPVTNGDTVKGHGSGLVRTQSEESRPQSLQQPATSTTETPASPAHTTPQTQNTSGRRRRAANEDPDEKRRKFLERNRAAASRCRQKRKVWVQSLEKKAEDLSSLNGQLQSEVTLLRNEVAQLKQLLLAHKDCPVTAMQKKSGYHTADKDDSSEDLSVPSSPHTEAIQHSSVSTSNGVSSTSKAEAVATSVLTQMADQSTEPALSQIVMAPPSQAQPSGS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
34 | Phosphorylation | HKHKHEMTLKFGPAR EECCCEEEEEECCCC | 24.66 | - | |
44 | Phosphorylation | FGPARNDSVIVADQT ECCCCCCCEEEECCC | 19.79 | 21082442 | |
51 | Phosphorylation | SVIVADQTPTPTRFL CEEEECCCCCCCHHH | 29.67 | 27087446 | |
53 | Phosphorylation | IVADQTPTPTRFLKN EEECCCCCCCHHHHC | 40.45 | 27087446 | |
55 | Phosphorylation | ADQTPTPTRFLKNCE ECCCCCCCHHHHCHH | 36.21 | 27742792 | |
72 | Phosphorylation | GLFNELASPFENEFK CCHHHHCCCCHHHHH | 42.62 | 27087446 | |
94 | Phosphorylation | KKMPLDLSPLATPII HHCCCCCCCCCCHHH | 19.96 | 25521595 | |
98 | Phosphorylation | LDLSPLATPIIRSKI CCCCCCCCHHHHHCC | 23.78 | 21082442 | |
103 | Phosphorylation | LATPIIRSKIEEPSV CCCHHHHHCCCCCCC | 27.81 | - | |
109 | Phosphorylation | RSKIEEPSVVETTHQ HHCCCCCCCEEECCC | 41.91 | 26643407 | |
113 | Phosphorylation | EEPSVVETTHQDSPL CCCCCEEECCCCCCC | 20.26 | 26745281 | |
114 | Phosphorylation | EPSVVETTHQDSPLP CCCCEEECCCCCCCC | 12.20 | 27087446 | |
118 | Phosphorylation | VETTHQDSPLPHPES EEECCCCCCCCCCCC | 23.05 | 25266776 | |
118 (in isoform 2) | Phosphorylation | - | 23.05 | 29514104 | |
125 | Phosphorylation | SPLPHPESTTSDEKE CCCCCCCCCCCCCCC | 41.24 | 26745281 | |
126 | Phosphorylation | PLPHPESTTSDEKEV CCCCCCCCCCCCCCC | 28.76 | 26745281 | |
127 | Phosphorylation | LPHPESTTSDEKEVP CCCCCCCCCCCCCCC | 43.38 | 26745281 | |
128 | Phosphorylation | PHPESTTSDEKEVPL CCCCCCCCCCCCCCC | 43.81 | 28066266 | |
235 | Phosphorylation | VPLVRPVTMVPSVPG ECEEEECEECCCCCC | 18.35 | 29233185 | |
239 | Phosphorylation | RPVTMVPSVPGIPGP EECEECCCCCCCCCC | 29.54 | 29233185 | |
247 | Phosphorylation | VPGIPGPSSPQPVQS CCCCCCCCCCCCCCC | 61.64 | 25159016 | |
248 | Phosphorylation | PGIPGPSSPQPVQSE CCCCCCCCCCCCCCH | 30.59 | 22942356 | |
254 | Phosphorylation | SSPQPVQSEAKMRLK CCCCCCCCHHHHHHH | 39.49 | 25159016 | |
265 | Phosphorylation | MRLKAALTQQHPPVT HHHHHHHHCCCCCCC | 22.81 | - | |
272 | Phosphorylation | TQQHPPVTNGDTVKG HCCCCCCCCCCCCCC | 38.98 | - | |
272 | O-linked_Glycosylation | TQQHPPVTNGDTVKG HCCCCCCCCCCCCCC | 38.98 | 22517741 | |
287 | Phosphorylation | HGSGLVRTQSEESRP CCCCCCCCCCCCCCC | 29.03 | 25159016 | |
289 | Phosphorylation | SGLVRTQSEESRPQS CCCCCCCCCCCCCCC | 42.59 | 21082442 | |
292 | Phosphorylation | VRTQSEESRPQSLQQ CCCCCCCCCCCCCCC | 45.25 | 25159016 | |
296 | Phosphorylation | SEESRPQSLQQPATS CCCCCCCCCCCCCCC | 30.72 | 25159016 | |
302 | Phosphorylation | QSLQQPATSTTETPA CCCCCCCCCCCCCCC | 33.03 | 25159016 | |
303 | Phosphorylation | SLQQPATSTTETPAS CCCCCCCCCCCCCCC | 35.12 | 25159016 | |
304 | Phosphorylation | LQQPATSTTETPASP CCCCCCCCCCCCCCC | 25.05 | 25159016 | |
305 | Phosphorylation | QQPATSTTETPASPA CCCCCCCCCCCCCCC | 37.31 | 25159016 | |
307 | Phosphorylation | PATSTTETPASPAHT CCCCCCCCCCCCCCC | 23.28 | 25159016 | |
310 | Phosphorylation | STTETPASPAHTTPQ CCCCCCCCCCCCCCC | 24.67 | 27087446 | |
314 | Phosphorylation | TPASPAHTTPQTQNT CCCCCCCCCCCCCCC | 42.13 | 25159016 | |
315 | Phosphorylation | PASPAHTTPQTQNTS CCCCCCCCCCCCCCC | 11.97 | 25159016 | |
318 | Phosphorylation | PAHTTPQTQNTSGRR CCCCCCCCCCCCCHH | 25.62 | 25159016 | |
321 | Phosphorylation | TTPQTQNTSGRRRRA CCCCCCCCCCHHHHH | 23.81 | 25159016 | |
322 | Phosphorylation | TPQTQNTSGRRRRAA CCCCCCCCCHHHHHC | 37.54 | 25159016 | |
339 | Acetylation | DPDEKRRKFLERNRA CCHHHHHHHHHHHHH | 59.33 | - | |
349 | Phosphorylation | ERNRAAASRCRQKRK HHHHHHHHHHHHHHH | 27.47 | - | |
356 | Acetylation | SRCRQKRKVWVQSLE HHHHHHHHHHHHHHH | 47.70 | - | |
391 | Ubiquitination | RNEVAQLKQLLLAHK HHHHHHHHHHHHHCC | 27.16 | - | |
409 | Phosphorylation | VTAMQKKSGYHTADK CEEEHHHCCCCCCCC | 52.17 | 26643407 | |
411 | Phosphorylation | AMQKKSGYHTADKDD EEHHHCCCCCCCCCC | 11.77 | 26643407 | |
413 | Phosphorylation | QKKSGYHTADKDDSS HHHCCCCCCCCCCCC | 28.24 | 26643407 | |
419 | Phosphorylation | HTADKDDSSEDLSVP CCCCCCCCCCCCCCC | 45.84 | 26643407 | |
420 | Phosphorylation | TADKDDSSEDLSVPS CCCCCCCCCCCCCCC | 41.97 | 26643407 | |
424 | Phosphorylation | DDSSEDLSVPSSPHT CCCCCCCCCCCCCCC | 44.28 | 26643407 | |
427 | Phosphorylation | SEDLSVPSSPHTEAI CCCCCCCCCCCCHHC | 55.11 | 26643407 | |
428 | Phosphorylation | EDLSVPSSPHTEAIQ CCCCCCCCCCCHHCC | 18.03 | 26643407 | |
431 | Phosphorylation | SVPSSPHTEAIQHSS CCCCCCCCHHCCCCC | 30.42 | 26643407 | |
437 | Phosphorylation | HTEAIQHSSVSTSNG CCHHCCCCCCCCCCC | 18.96 | 26643407 | |
438 | Phosphorylation | TEAIQHSSVSTSNGV CHHCCCCCCCCCCCC | 20.26 | 26643407 | |
440 | Phosphorylation | AIQHSSVSTSNGVSS HCCCCCCCCCCCCCC | 28.24 | 26643407 | |
441 | Phosphorylation | IQHSSVSTSNGVSST CCCCCCCCCCCCCCC | 24.85 | 26643407 | |
442 | Phosphorylation | QHSSVSTSNGVSSTS CCCCCCCCCCCCCCH | 24.87 | 26643407 | |
446 | Phosphorylation | VSTSNGVSSTSKAEA CCCCCCCCCCHHHHH | 29.33 | 26643407 | |
447 | Phosphorylation | STSNGVSSTSKAEAV CCCCCCCCCHHHHHH | 34.00 | 26643407 | |
448 | Phosphorylation | TSNGVSSTSKAEAVA CCCCCCCCHHHHHHH | 27.09 | 26643407 | |
449 | Phosphorylation | SNGVSSTSKAEAVAT CCCCCCCHHHHHHHH | 31.64 | 26643407 | |
472 | Phosphorylation | QSTEPALSQIVMAPP CCCCCHHHHHEECCH | 21.70 | - | |
480 | Phosphorylation | QIVMAPPSQAQPSGS HHEECCHHHCCCCCC | 36.77 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
34 | T | Phosphorylation | Kinase | PRKCH | P23298 | Uniprot |
51 | T | Phosphorylation | Kinase | MAPK11 | Q9WUI1 | Uniprot |
51 | T | Phosphorylation | Kinase | P38A | P47811 | PSP |
51 | T | Phosphorylation | Kinase | MAPK9 | P45984 | GPS |
51 | T | Phosphorylation | Kinase | P38A | Q16539 | PSP |
51 | T | Phosphorylation | Kinase | MAPK8 | Q91Y86 | GPS |
51 | T | Phosphorylation | Kinase | JNK1 | P45983 | PSP |
53 | T | Phosphorylation | Kinase | ERK2 | P63085 | PSP |
53 | T | Phosphorylation | Kinase | MAPK9 | P45984 | GPS |
53 | T | Phosphorylation | Kinase | MAPK8 | Q91Y86 | GPS |
53 | T | Phosphorylation | Kinase | JNK1 | P45983 | PSP |
53 | T | Phosphorylation | Kinase | ERK1 | Q63844 | PSP |
53 | T | Phosphorylation | Kinase | ERK1 | P27361 | PSP |
53 | T | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
53 | T | Phosphorylation | Kinase | MAPK11 | Q9WUI1 | Uniprot |
53 | T | Phosphorylation | Kinase | MAPK12 | O08911 | Uniprot |
53 | T | Phosphorylation | Kinase | P38A | Q16539 | PSP |
53 | T | Phosphorylation | Kinase | P38A | P47811 | PSP |
53 | T | Phosphorylation | Kinase | PLK3 | Q60806 | Uniprot |
55 | T | Phosphorylation | Kinase | VRK1 | Q80X41 | Uniprot |
103 | S | Phosphorylation | Kinase | PRKCB | P68404 | Uniprot |
103 | S | Phosphorylation | Kinase | PRKCA | P20444 | Uniprot |
322 | S | Phosphorylation | Kinase | PRKCB | P68404 | Uniprot |
322 | S | Phosphorylation | Kinase | PRKCA | P20444 | Uniprot |
349 | S | Phosphorylation | Kinase | PRKCB | P68404 | Uniprot |
349 | S | Phosphorylation | Kinase | PRKCA | P20444 | Uniprot |
472 | S | Phosphorylation | Kinase | ATM | Q62388 | Uniprot |
480 | S | Phosphorylation | Kinase | ATM | Q62388 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
44 | S | Phosphorylation |
| - |
51 | T | Acetylation |
| - |
51 | T | Phosphorylation |
| - |
51 | T | Phosphorylation |
| - |
53 | T | Acetylation |
| - |
53 | T | Phosphorylation |
| - |
53 | T | Phosphorylation |
| - |
55 | T | Phosphorylation |
| - |
103 | S | Phosphorylation |
| - |
472 | S | Phosphorylation |
| - |
480 | S | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ATF2_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
BARX2_MOUSE | Barx2 | physical | 20211142 | |
ATF2_MOUSE | Atf2 | physical | 12052888 | |
EP300_MOUSE | Ep300 | physical | 10327051 | |
JDP2_MOUSE | Jdp2 | physical | 11231009 | |
SSXT_MOUSE | Ss18 | physical | 22439931 | |
TLE1_MOUSE | Tle1 | physical | 22439931 | |
BRCA1_MOUSE | Brca1 | physical | 17700520 | |
PO2F1_MOUSE | Pou2f1 | physical | 17700520 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-94, AND MASSSPECTROMETRY. | |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-51 AND THR-53, AND MASSSPECTROMETRY. |